Asthma Market 2019-2026
New Market Study, Report “Asthma Market 2019 Global Industry Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2026” Has been Added on WiseGuyReports.com.
This report provides in depth study of “Asthma Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Asthma Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
Asthma is a recurring disease which causes inflammation of the air passage in the throat, reversible airflow obstruction, and bronchial hypersensitivity. Asthma is normally brought on by environmental factors, and its symptoms include laboured breathing, coughing, wheezing, and occasionally a potentially fatal asthma attack. Even though there is no permanent cure yet, the symptoms of asthma can be treated to make the patient’s condition more bearable, by increasing or decreasing the degree in which various treatments are applied.
In a recently published report, the primary symptoms and co-morbidities linked to asthma have been assessed and presented along with information on the prevalence of each of these co-morbidities. The report also offers a country-level analysis of these sub-divisions within the global asthma patient population across a ten-year forecast period. The most well-known co-morbidities usually associated with asthma are obesity, smoking, COPD (Chronic Obstructive Pulmonary Disease), GERD (Gastroesophageal reflux disease), and various sleep disorders.
This report analyses the prevalent asthma patient population across eight of the largest asthma markets in the world, segmented by gender and a five-year age cohort. It also offers a general overview of asthma, taking into consideration the various risk factors, and diagnosis and prognosis of the disease, along with variations based on geography and ethnicity. It sources information from a proprietary Epiomic patient segmentation database which utilises a combination of many world class sources, and consequently it gives the most updated data from sources like patient registry records, clinical trials, and epidemiology studies.
Request for Free Sample Report of “Asthma” Market @ https://www.wiseguyreports.com/sample-request/3028458-epiomic-epidemiology-series-asthma-forecast-in-8-major-markets-2016-2026
Asthma can be of four types: exercise-induced asthma, childhood asthma, allergic asthma, and occupational asthma.
Depending on the class of drug, asthma market can be segmented into bronchodilators, mast cell stabilizers, leukotriene antagonists, immuno-suppressants, and a combination of ICS/LABA.
The report offers excellent insights into the prevalence of each of the different types of asthma, and helps in the identification of patient segments with the highest potential.
The prevalence of asthma has also been analysed on the basis of gender and age in eight different asthma markets across the globe, which are the United States of America, France, Germany, Italy, Spain, UK, Brazil and Japan. In a study conducted in 2003, the highest prevalence of twenty percent or more was generally observed in the Anglophone countries of Australasia, Europe and North America, as well as in parts of Latin America. The lowest prevalence of five percent or less was found in India and other countries in the Asia-Pacific region, eastern Mediterranean countries, and northern and eastern Europe.
In 2016, a study reported that there had been a 3.6 percent rise in the global prevalence of asthma since 2006. WHO (World Health Organisation) reports that 235 million people suffer from asthma currently and that most deaths occur in older adults. Asthma does not only affect wealthy nations, but it plagues all countries, regardless of economic prosperity. A large chunk of asthma-related deaths take place in low and lower-middle income countries. Inhaled corticosteroids and other forms of asthma medication are required to keep the spread of asthma in check.
If you have any special requirements, please let us know and we will offer you the report as you want.
Leave Query Related to Report@ https://www.wiseguyreports.com/enquiry/3028458-epiomic-epidemiology-series-asthma-forecast-in-8-major-markets-2016-2026
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)